Information Provided By:
Fly News Breaks for September 30, 2015
OVAS
Sep 30, 2015 | 09:23 EDT
Oppenheimer cut its price target on OvaScience after the company withdrew its 2015 AUGMENT cycles guidance. The firm is more conservative on the outlook for AUGMENT's growth but continues to believe in the technology. It keeps an Outperform rating on the shares.
News For OVAS From the Last 2 Days
There are no results for your query OVAS